Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The Activa™ RC system puts a more precise programming experience in your hands, and delivers a refreshed, wireless recharging experience with unmatched MRI access to your patients.
Download the brochureHelp your patients take charge
The Activa™ Rechargeable system, now compatible with our SenSight™ directional lead so you can program with more precision and your patients can benefit from a proven 15-year battery life and full-body MRI access.
Mission driven. Patient focused.
With the complete Activa™ RC Neurostimulator and SenSight™ Directional Lead System your patients benefit from:
Meet the refreshed recharger experience
Help your patients take charge with a wireless recharger that’s faster‡, easier to use, and provides more flexibility and customization than ever.
Keeps therapy on with an altogether smarter experience.
Activa™ RC product details
Proven battery performance
In 2009, when we launched the first rechargeable technology in the DBS market, we felt confident that our devices would provide predictable performance for up to nine years. This confidence was based largely on accelerated lab-testing.
Today, as part of our commitment to the Medtronic mission and to DBS therapy, we have invested in post-market analysis and continuous device testing to validate our predictive models, and confidently extend device service life from 9 to 15 years.†
Programming options
Establish programming groups that may allow patients to reach optimized settings sooner.
Achieve finer control over the stimulation field by delivering multiple programs per lead.
1-3-3-1 electrode configuration to more precisely direct the stimulation.
MR Conditional*
The Activa™ RC DBS system is ready for today’s imaging needs: Eligible patients with an Activa™ RC neurostimulator may have an MRI scan anywhere on the body under certain conditions.
Refer to the MRI Guidelines for Medtronic Deep Brain Stimulation Systems and DBS MRI Eligibility Report for a complete list of conditions and instructions for use.
Clinician programmer
The DBS clinician programmer is now even more feature-rich and ready to streamline your programming session with the information you need, quickly and intuitively.
Insightful.
Intuitive.
Streamlined.
Secure, patient-focused programming, streamlined workflows, and actionable insights are more accessible than ever.
Patient programmer
The familiar interface of the DBS patient programmer helps build confidence while enabling patients to manage their DBS therapy on a device that looks like a smartphone. They’ll appreciate the ease of use, and you’ll appreciate how simple the programmer is for patients to learn and use.
Activa™ RC neurostimulator
Compatible with:
Model specifications
Model |
37612 |
---|---|
Battery Type |
Rechargeable |
Weight |
40g (1.4oz) |
Height |
54mm (2.1in) |
Length |
54mm (2.1in) |
Channels |
2 |
Clinician services
800-707-0933
Medtronic DBS systems are MR Conditional and safe in the MR environment as long as certain conditions are met. If the conditions are not met, a significant risk is tissue lesions from component heating, especially at the lead electrodes, resulting in serious and permanent injury including coma, paralysis, or death. Refer to the MRI Guidelines for Medtronic Deep Brain Stimulation Systems for a complete list of conditions.
Activa™ RC devices eligible for the service life extension and the supplemental limited warranty are those devices sold in the US that have been successfully interrogated with the Medtronic Activa Clinician Programmer (tablet) prior to reaching End of Service (EOS). For more information on the warranty contact rs.rtgwarranty@medtronic.com.
Humanitarian Device: Medtronic DBS Therapy has been authorized by Federal Law for the use as an aid in the management of chronic, intractable (drug refractory) primary dystonia and for people with chronic, severe, treatment-resistant obsessive-compulsive disorder. The effectiveness of this device for these uses has not been demonstrated.